Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Neuronetics Q3 EPS $(0.33) Misses $(0.31) Estimate, Sales $17.88M Beat $17.58M Estimate

Author: Benzinga Newsdesk | November 07, 2023 08:31am
Neuronetics (NASDAQ:STIM) reported quarterly losses of $(0.33) per share which missed the analyst consensus estimate of $(0.31) by 6.45 percent. This is a 17.86 percent decrease over losses of $(0.28) per share from the same period last year. The company reported quarterly sales of $17.88 million which beat the analyst consensus estimate of $17.58 million by 1.73 percent. This is a 8.40 percent increase over sales of $16.50 million the same period last year.

Posted In: STIM


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist